VTRS Viatris Inc.
Healthcare$16.26-2.34%ClosedMarket Cap: $18.94B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.31
P/S
1.33
EV/EBITDA
16.90
DCF Value
$23.26
FCF Yield
8.8%
Div Yield
2.9%
Margins & Returns
Gross Margin
34.4%
Operating Margin
1.0%
Net Margin
-2.0%
ROE
-2.0%
ROA
-0.8%
ROIC
0.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.52B | 32.9% | $-79.7M | $176.4M | $— | $0.12 |
| Q4 null | $3.70B | 30.6% | $-265.5M | $-340.1M | $— | $0.12 |
| FY null | $14.30B | 35.1% | $-2.66B | $-3.51B | $— | $0.48 |
| Q3 null | $3.76B | 36.8% | $251.6M | $-128.2M | $— | $0.12 |
| Q2 null | $3.58B | 37.2% | $233.0M | $-4.6M | $— | $0.12 |
| Q1 null | $3.25B | 35.7% | $-2.88B | $-3.04B | $— | $0.12 |
| Q4 null | $3.53B | 34.4% | $-179.8M | $-516.5M | $— | $0.12 |
| FY null | $14.74B | 38.2% | $10.1M | $-634.2M | $— | $0.48 |
| Q3 null | $3.75B | 38.9% | $225.9M | $94.8M | $— | $0.12 |
| Q2 null | $3.80B | 38.1% | $-239.9M | $-326.4M | $— | $0.12 |
| Q1 null | $3.66B | 41.1% | $203.9M | $113.9M | $— | $0.12 |
| Q4 2023 | $3.84B | 41.6% | $-454.5M | $-765.6M | $-0.64 | $0.12 |